Our Services
Medical Information
Helpful Resources
Published on: 4/28/2026
Anti-VEGF injections transformed diabetic retinopathy treatment by blocking VEGF to reduce retinal vessel leakage and prevent abnormal vessel growth, helping preserve and sometimes improve vision.
There are several important factors to consider, including injection schedules, possible side effects, monitoring requirements, and diabetes management. See complete details below to understand what to expect and which next steps might be best for your care.
Diabetic retinopathy is a leading cause of vision loss among people with diabetes. High blood sugar levels can damage the small blood vessels in the retina, leading to leakage, swelling and the growth of fragile new vessels. Without treatment, this damage can progress to serious vision impairment or blindness.
Anti-VEGF injections have transformed care for diabetic retinopathy. By targeting vascular endothelial growth factor (VEGF), these treatments reduce leakage and abnormal vessel growth, helping to preserve—and sometimes improve—vision.
VEGF is a protein that stimulates the formation of new blood vessels (angiogenesis). In diabetes, chronic high glucose levels:
Excess VEGF leads to:
By blocking VEGF, anti-VEGF injections halt these processes.
Anti-VEGF injections are medications delivered directly into the eye's vitreous cavity. Commonly used agents include:
These drugs bind to VEGF molecules, preventing them from attaching to receptors on blood vessel walls. As a result, they:
Anti-VEGF injections are outpatient treatments performed by an ophthalmologist:
No stitches are needed. Most people experience only mild discomfort.
A typical anti-VEGF regimen for diabetic retinopathy injections may include:
Some protocols use "treat and extend," lengthening intervals when the retina remains stable.
Clinical studies show that anti-VEGF injections can:
Compared with older treatments (laser photocoagulation), injections offer:
Anti-VEGF injections are generally well tolerated. Possible side effects include:
Common (mild):
Uncommon (serious):
Your doctor will discuss risks and signs to watch for, such as:
Prompt medical attention can address complications early.
Regular follow-up helps ensure the treatment is working:
These assessments guide decisions about continuing, adjusting or extending injection intervals.
Combining injections with good diabetes management maximizes benefits:
Staying proactive helps protect your vision and overall health.
Early detection matters. If you have diabetes and notice blurred vision, floaters, or dark spots in your field of view, use our free AI-powered Diabetic Retinopathy symptom checker to understand your risk and determine if you should schedule a comprehensive eye exam.
Anti-VEGF injections offer a powerful way to stop or slow vision loss in diabetic retinopathy. However, if you experience:
…you should seek prompt medical care. Always speak to a doctor about anything that could be life-threatening or serious.
Your ophthalmologist can help tailor a treatment plan to your needs. Together, you can work toward preserving your vision and quality of life.
(References)
* El-SNH, et al. Anti-VEGF Therapy for Diabetic Retinopathy and Diabetic Macular Edema: A Review. *Cells*. 2021 Oct 21;10(11):2841. doi: 10.3390/cells10112841. PMID: 34831102; PMCID: PMC8615024.
* Zafar S, et al. Mechanism of Action of Anti-VEGF in Diabetic Macular Edema. *J Clin Med*. 2022 Nov 9;11(22):6626. doi: 10.3390/jcm11226626. PMID: 36431980; PMCID: PMC9692482.
* Ercan YKS, et al. Molecular Mechanisms of Anti-VEGF Treatment in Diabetic Retinopathy. *Int J Mol Sci*. 2023 Apr 19;24(8):7470. doi: 10.3390/ijms24087470. PMID: 37175850; PMCID: PMC10196887.
* Nogueira BB, et al. Vascular Endothelial Growth Factor and Diabetic Retinopathy: Pathophysiological Implications and Therapeutic Opportunities. *Front Endocrinol (Lausanne)*. 2022 Feb 14;13:836468. doi: 10.3389/fendo.2022.836468. PMID: 35237397; PMCID: PMC8884940.
* Cheetham JK, et al. Diabetic Retinopathy: From Pathophysiology to Novel Therapeutic Targets. *Int J Mol Sci*. 2023 Jul 26;24(15):12019. doi: 10.3390/ijms241512019. PMID: 37569106; PMCID: PMC10431388.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.